CDHA CAAR

“Concurrent Anticholinergic and Acetylcholinesterase Inhibitor Drug Use Among Older Adults with Dementia: Commonly Done; Never Advised,” by Elizabeth A. Carter and Erwin J. Tan (June 2021, .pdf format, 4p.).

www.aarp.org/ppi/info-2021/concurrent-inhibitor-drug-use-among-older-adults-with-dementia.html

“A data-driven prospective study of dementia among older adults in the United States,” by Jordan Weiss, Eli Puterman, Aric A. Prather, Erin B. Ware, and David H. Rehkopf (PLoS ONE 15(10): e0239994. doi.org/10.1371/journal.pone.0239994, XML, HTML, and .pdf format, 15p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0239994

“Dementia data gaps and opportunities,” (September 2020, .pdf and HTML format, 88p.).

www.aihw.gov.au/reports/dementia/dementia-data-gaps-and-opportunities/contents/summary

“What older adults do with the results of dementia screening programs,” by James E. Galvin, Magdalena I. Tolea, and Stephanie Chrisphonte (PLoS ONE 15(7): e0235534. doi.org/10.1371/journal.pone.0235534, HTML, XML, and .pdf format, 19p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0235534

“Behavioural issues in late life may be the precursor of dementia – A cross sectional evidence from memory clinic of AIIMS, India,” by Abhijith Rajaram Rao, Prasun Chatterjee, Meenal Thakral, S. N. Dwivedi, and Aparajit Ballav Dey (PLoS ONE 15(6): e0234514. doi.org/10.1371/journal.pone.0234514, XML, HTML, and .pdf format, 10p.).

journals.plos.org/plosone/article?id=10.1371/journal.pone.0234514

Note: Check with your organization’s library for availability. “Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study,” by Katrina M. Moore, Jennifer Nicholas, Murray Grossman, Corey T McMillan, David J. Irwin, Lauren Massimo, Vivianna M. Van Deerlin, Jason D. Warren, Nick C. Fox, Martin N. Rossor, Simon Mead, Martina Bocchetta, Bradley F. Boeve, David S. Knopman, Neill R. Graff-Radford, Leah K. Forsberg, Rosa Rademakers, Zbigniew K. Wszolek, John C. van Swieten, Lize C. Jiskoot, Lieke H. Meeter, Elise G.P. Dopper, Janne M. Papma, Julie S. Snowden, Jennifer Saxon, Matthew Jones, Stuart Pickering-Brown, Isabelle Le Ber, Agnès Camuzat, Alexis Brice, Paola Caroppo, Roberta Ghidoni, Michela Pievani, Luisa Benussi, Giuliano Binetti, Bradford C Dickerson, Diane Lucente, Samantha Krivensky, Caroline Graff, Linn Öijerstedt, Marie Fallstrom, Hakan Thonberg, Nupur Ghoshal, John C. Morris, Barbara Borroni, Alberto Benussi, Alessandro Padovani, Daniela Galimberti, Elio Scarpini, Giorgio G. Fumagalli, Ian R. Mackenzie, Ging-Yuek R. Hsiung, Pheth Sengdy, Adam L. Boxer, Howie Rosen, Joanne B. Taylor, Matthis Synofzik, Carlo Wilke, Patricia Sulzer, John R. Hodges, Glenda Halliday, John Kwok, Raquel Sanchez-Valle, Albert Lladó, Sergi Borrego-Ecija, Isabel Santana, Maria Rosário Almeida, Miguel Tábuas-Pereira, Fermin Moreno, Myriam Barandiaran, Begona Indakoetxea, Johannes Levin, Adrian Danek, James B. Rowe, Thomas E. Cope, Markus Otto, Sarah Anderl-Straub, Alexandre de Mendonça, Carolina Maruta, Mario Masellis, Sandra E. Black, Philippe Couratier, Geraldine Lautrette, Edward D. Huey, Sandro Sorbi, Benedetta Nacmias, Robert Laforce Jr., Marie-Pier L. Tremblay, Rik Vandenberghe, Philip Van Damme, Emily J. Rogalski, Sandra Weintraub, Alexander Gerhard, Chiadi U. Onyike, Simon Ducharme, Sokratis G. Papageorgiou, Adeline Su Lyn Ng, Amy Brodtmann, Elizabeth Finger, Rita Guerreiro, Jose Bras, and Jonathan D. Rohrerfor the FTD Prevention Initiative (Vol. 19, No. 2, February 2020, p. 145-156).

www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30394-1/fulltext

“Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study,” by Emma L. van der Ende, Lieke H. Meeter, Jackie M. Poos, Jessica L. Panman, Lize C. Jiskoot, Elise G. P. Dopper, Janne M. Papma, Frank Jan de Jong, Inge M. W. Verberk, Charlotte Teunissen, Dimitris Rizopoulos, Carolin Heller, Rhian S. Convery, Katrina M. Moore, Martina Bocchetta, Mollie Neason, David M. Cash, Barbara Borroni, Daniela Galimberti, Raquel Sanchez-Valle, Robert Laforce Jr., Fermin Moreno, Matthis Synofzik, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Rik Vandenberghe, Elizabeth Finger, Fabrizio Tagliavini, Alexandre de Mendonça, Isabel Santana, Chris Butler, Simon Ducharme, Alex Gerhard, Adrian Danek, Johannes Levin, Markus Otto, Giovanni B. Frisoni, Stefano Cappa, Yolande A. L. Pijnenburg, Jonathan D. Rohrer, and John C. van Swietenon behalf of the Genetic Frontotemporal dementia Initiative (GENFI) (Vol. 18, No. 12, December 2019, p. 1103-1111). Note: Check with you organization’s library for availability.

www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30354-0/fulltext

“Reducing the Cost and Risk of Dementia: Recommendations to Improve Brain Health and Decrease Disparities,” by Nora Super, Rajiv Ahuja, and Kevin Proff (October 2019, .pdf format, 61p.).

milkeninstitute.org/reports/reducing-cost-and-risk-dementia

“Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population,” by Silvan Licher, Shahzad Ahmad, Hata Karamujić-Čomić, Trudy Voortman, Maarten J. G. Leening, M. Arfan Ikram & M. Kamran Ikram (Vol. 25, No. 9, September 2019, p. 1364-1369).

www.nature.com/articles/s41591-019-0547-7